2026年8月31日 / 美国东部时间下午4:38 / 哥伦比亚广播公司新闻（CBS News）
作者：玛丽·坎宁安
玛丽·坎宁安是哥伦比亚广播公司财经观察频道（CBS MoneyWatch）记者。她曾供职于《60分钟》、哥伦比亚广播公司新闻网（CBSNews.com）及哥伦比亚广播公司24小时新闻频道，为哥伦比亚广播公司新闻实习生计划成员。查看完整简历
特朗普总统周一表示，其政府已与另外9家制药公司签署协议，为州医疗补助计划提供折扣药品。
“总体而言，这些协议预计将在极短时间内为美国人节省超过6000亿美元，”特朗普先生在椭圆形办公室的发布会上说道。
此次发布是特朗普“最惠国”药品定价政策的一部分，该政策旨在让美国境内的药品价格与其他发达国家保持相当。这项计划通过特朗普Rx网站直接向消费者销售折扣药品，该网站由特朗普政府于今年2月推出，美国人可在此获得品牌处方药折扣。
据白宫消息，过去一年已有17家制药公司自愿同意根据“最惠国”协议降低药品价格。
“随着今天的宣布，我们现在已有26家公司，覆盖了90%的国内制药市场，剩下的10%也即将加入，”特朗普先生表示，“他们别无选择。”
据白宫情况说明书显示，新同意提供消费者折扣的9家公司均为中型制药企业，其中包括爱尔康（Alcon）、安斯泰来制药（Astellas Pharma）、BeOne Medicines、BridgeBio、CSL、协和麒麟（Kyowa Kirin）、太阳制药（Sun Pharma）、梯瓦制药（Teva Pharmaceuticals）及优时比（UCB）。
白宫表示，这些公司将向美国所有州医疗补助计划提供其药品，“这将为美国人带来数十亿美元的储蓄”。
据特朗普政府透露，这些公司还承诺投入196亿美元用于制造业。
编辑：阿兰·谢尔特（Alain Sherter）
https://www.cbsnews.com/video/are-trump-administrations-efforts-lower-drug-costs-working/
Trump announces deal with 9 new pharmaceutical firms in move to ease drug costs
August 31, 2026 / 4:38 PM EDT / CBS News
By Mary Cunningham
Mary Cunningham is a reporter for CBS MoneyWatch. She previously worked at “60 Minutes,” CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program. Read Full Bio
President Trump said Monday that his administration has signed agreements with nine additional pharmaceutical firms to offer discounted drugs to state Medicaid programs.
“In total, these agreements are projected to save Americans more than $600 billion over a very short period of time,” Mr. Trump said during an announcement at the Oval Office.
The announcement is part of Mr. Trump’s “most-favored-nation” drug pricing policy, aimed at offering drugs in the U.S. at a comparable price to that in other developed nations. The effort involves selling discounted drugs directly to consumers on TrumpRx, a website the Trump administration launched in February, where Americans can get discounts on name-brand medications.
Seventeen pharmaceutical companies have already agreed to voluntarily lower their drug prices as part of the “most favored nation” deal over the last year, according to the White House.
“With today’s announcement, we now have 26 companies representing 90% of the domestic pharmaceutical market, and the other 10% are also coming in,” Mr. Trump said. “They have no choice.”
The nine new firms that have agreed to offer consumer discounts are midsize pharmaceutical firms, according to a White House fact sheet. They include Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB.
The White House said the companies will provide access to their drugs to every state Medicaid program in the U.S., “resulting in billions of dollars in savings for Americans.”
The companies have also committed to spending $19.6 billion on manufacturing, according to the Trump administration.
Edited by Alain Sherter
https://www.cbsnews.com/video/are-trump-administrations-efforts-lower-drug-costs-working/
发表回复